BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25798836)

  • 1. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
    Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
    Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIS21
    Lim IK; Choi JA; Kim EY; Kim BN; Jang S; Ryu MS; Shim SH
    Cell Signal; 2017 Jan; 30():179-190. PubMed ID: 27932314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIS21
    Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells.
    Choi JA; Lim IK
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1657-65. PubMed ID: 23907596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
    Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
    Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
    Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
    FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
    Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
    Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
    Imran M; Lim IK
    Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
    Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
    Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
    Tirone F
    J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
    Imran M; Park TJ; Lim IK
    Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
    Lim YB; Park TJ; Lim IK
    J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
    Lim IK
    J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes.
    Micheli L; Ceccarelli M; Farioli-Vecchioli S; Tirone F
    J Cell Physiol; 2015 Dec; 230(12):2881-90. PubMed ID: 25967096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
    Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
    Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
    Zubair H; Lim IK; Safi SZ; Rehman F; Imran M
    Ann Clin Lab Sci; 2020 Nov; 50(6):711-716. PubMed ID: 33334784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating IκBα degradation in normal and cancer cells.
    Sundaramoorthy S; Ryu MS; Lim IK
    Cell Commun Signal; 2013 Sep; 11():69. PubMed ID: 24047462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of B-cell translocation gene 2 protein in normal human tissues.
    Melamed J; Kernizan S; Walden PD
    Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression.
    Micheli L; D'Andrea G; Leonardi L; Tirone F
    J Cell Physiol; 2017 Jul; 232(7):1696-1707. PubMed ID: 27333946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
    Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.